The human MN blood group antigens are isoforms of glycophorin A (GPA) encoded by the gene, GYPA, and are the most abundant erythrocyte sialoglycoproteins. The distribution of MN antigens has been widely studied in human populations yet the evolutionary and/or demographic factors affecting population variation remain elusive. While the primary function of GPA is yet to be discovered, it serves as the major binding site for the 175-kD erythrocyte-binding antigen (EB-175) of the malarial parasite, Plasmodium falciparum, a major selective pressure in recent human history. More specifically, exon two of GYPA encodes the receptor-binding ligand to which P. falciparum binds. Accordingly, there has been keen interest in understanding what impact, if any, natural selection has had on the distribution of variation in GYPA and exon two in particular. To this end, we resequenced GYPA in individuals sampled from both P. falciparum endemic (sub-Saharan Africa and South India) and non-endemic (Europe and East Asia) regions of the world. Observed patterns of variation suggest that GYPA has been subject to balancing selection in populations living in malaria endemic areas and in Europeans, but no such evidence was found in samples from East Asia, Oceania, and the Americas. These results are consistent with malaria acting as a selective pressure on GYPA, but also suggest that another selective force has resulted in a similar pattern of variation in Europeans. Accordingly, GYPA has perhaps a more complex evolutionary history, wherein on a global scale, spatially varying selective pressures have governed its natural history.
Introduction
Infectious diseases have been a major selective force during the evolution and differentiation of human populations (Bamshad and Wooding 2003; Barreiro and Quintana-Murci 2010) . Many of the genes exhibiting the strongest signatures of positive selection (e.g., elevated Ka/Ks ratios, elevated dN/dS ratios, and high F ST ) in the human lineage encode proteins involved in immunity (Nielsen et al. 2007) , and changes in patterns of polymorphism in response to specific pathogens have been documented for multiple loci (Saunders et al. 2002; Verrelli et al. 2002; Wood et al. 2005 ). Yet, much remains to be learned about the impact of pathogens on patterns of human genetic variation.
A common means by which pathogens infect humans is to usurp cell-surface glycoproteins that serve as receptors for endogenous ligands (Karlsson 1995) . One canonical family of cell-surface receptors that appear to have been exploited in such a way is the glycophorins, encoded by three closely linked paralogous genes (GYPA, GYPB, and GYPE) that have arisen through gene duplication (Onda et al. 1994; Rearden et al. 1993) . Located in tandem on the long arm of chromosome 4q28-31, GYPA, GYPB, and GYPE are some of the fastest evolving genes in the human lineage (Rearden et al. 1993; Wang et al. 2003) . GYPA and GYPB encode GPA and GPB, respectively. Variants of GPA represent M and N antigens of the MNS blood group system and GPB the S antigen.
A high non-synonymous substitution rate has been observed for GYPA in humans and its orthologs in chimp, gorilla, orangutan, gibbon, and macaque (Baum et al. 2002;  Electronic supplementary material The online version of this article (http s://doi.org/10.1007 /s004 39-018-1866 -3) contains supplementary material, which is available to authorized users. Wang et al. 2003) . The evolutionary forces that have affected GYPA have been of particular interest, because GPA is the major receptor to which Plasmodium falciparum, the most virulent species of malaria infecting humans, binds to gain cell entry. Specifically, the 175-kD erythrocyte-binding antigen (EBA-175) of P. falciparum recognizes and docks to a receptor-binding ligand on GPA (Camus and Hadley 1985; Chitnis and Miller 1994; Sim et al. 1994; Tolia et al. 2005) . However, while the GPA-dependent pathway is the major means by which P. falciparum invades human cells, haematologically normal individuals lacking both GPA and GPB on their erythrocyte surface can be infected with P. falciparum via a GPA-independent pathway (Okoyeh et al. 1999; Pasvol et al. 1982) .
Two hypotheses have been proposed to explain the rapid evolution of GYPA. Baum et al. proposed that GPA acts as a "decoy" receptor, whereby pathogens bind to GPA on an erythrocyte instead of binding to their target cells (Baum et al. 2002) . This hypothesis was based on two observations. First, GPA binds multiple infectious agents including viruses and bacteria (Baseman et al. 1982; Brooks et al. 1989; Nishimura et al. 1988; Paul and Lee 1987; Saada et al. 1991; Tavakkol and Burness 1990; Wybenga et al. 1996) . Second, the erythrocyte is an optimal decoy, because it lacks a nucleus. Therefore, invading viruses do not have access to the cellular machinery necessary for replication (Gagneux and Varki 1999) . In contrast, Wang et al. (2003) posited that GYPA has co-evolved with EBA-175 based on relatively weak evidence that both GYPA and the gene that encodes EBA-175 appear to have been subject to recent positive selection. More recently, Ko et al. (Ko et al. 2011) found a significant correlation between malaria exposure and a skew in the distribution of intermediate frequency alleles observed among populations from sub-Saharan Africa. They suggested that this observation was best explained by a combination of balancing selection and gene conversion acting on GYPA.
Results
We investigated the global pattern of single-nucleotide variants (SNVs) at the GYPA locus using DNA resequencing data from a sample of populations from sub-Saharan Africa, Europe, East Asia, South Asia, Oceania, and the Americas. Tests for departures from neutrality were performed and the results from populations living in geographic regions of endemic P. falciparum (South Asia and sub-Saharan Africa) were compared to those from populations indigenous to nonendemic zones (East Asia, Europe, Oceania, and the Americas). Observed patterns of variation suggest that GYPA has been subject to balancing selection in populations living in malaria endemic areas. Of populations living in malaria non-endemic areas, no such evidence was found in samples from East Asia, Oceania, and the Americas, but was found in samples from Europe. While these results are consistent with malaria acting as a selective pressure on GYPA, they also suggest that another selective force has resulted in a similar pattern of variation in Europeans. Accordingly, GYPA has perhaps a more complex evolutionary history wherein on a global scale, spatially varying selective pressures have governed its natural history.
Sequence Variation across GYPA
We characterized the pattern of nucleotide diversity across GYPA in 85 individuals who are members of populations residing in regions, where P. falciparum is endemic, subSaharan Africa, and South Asia, and regions where it is non-endemic, East Asia, and Europe ( Fig. 1 and Table S1 ). Sequence data were obtained for each exon and ~ 1 kb upstream and downstream of each exon. Across all four populations, 37 variable sites were identified including five insertion/deletion (indel) polymorphisms and 32 single SNVs. The majority of these variants were intronic. Five SNVs, four of which were located in exon two (Fig. 2) , were predicted to cause non-synonymous amino-acid substitutions. A single synonymous SNV was identified in exon two. In addition, two SNVs were identified in the 5′ UTR and one SNV was found in the 3′ UTR of GYPA. Both the SNVs that distinguish the MN blood groups were present, and MN allele frequencies and genotypes were consistent with published results (Table S2) (Mourant 1954; Race and Sanger 1975) .
If GYPA was subject to balancing selection from P. falciparum, we may well expect to observe relatively high levels of nucleotide diversity combined with departures from neutral expectations in populations living in regions, where P. falciparum was endemic. Accordingly, we tested if patterns of nucleotide diversity and results of neutrality tests differed for populations living in malarial endemic zones compared to populations from non-endemic zones. Nucleotide diversity ranged from π = 0.128 in South Asians to π = 0.17 in sub-Saharan Africans with π estimates for European and East Asian populations falling in between, π = 0.13 and π = 0.15, respectively ( estimates of π were relatively low in sub-Saharan Africans (< 5%), Europeans (< 5%), and E. Asians (< 10%). Collectively, nucleotide variation in GYPA was lower than in more than 90% of known genes. Thus, if balancing selection acted on GYPA, it has not manifested as an excess of nucleotide diversity.
Next, we calculated F ST between continental groups. F ST is a measure of population divergence characterizing the degree of genetic differentiation between two or more tide is purple, the extracellular domain is blue, the transmembrane domain is green, and the intracellular domain is yellow. Non-synonymous changes are indicated with an asterisk populations. Estimates of F ST that are higher than expected under expectations of neutrality may be the result of geographically restricted natural selection in one or more populations. Estimates of F ST differed significantly (p < 0.5) between populations from sub-Saharan Africa and all other populations, with the F ST between populations from subSaharan Africa and East Asia being the lowest (Table 2) . No pairwise F ST estimate between South Asians and Europeans and East Asians reached statistical significance (Table 2) .
To place our F ST estimates for GYPA in a genomewide context, we estimated F ST for all genes (n = 16,911) and a subset of genes that encode extracellular proteins (n = 1790), assessed as part of the EGP. Pairwise GYPA F ST estimates between sub-Saharan Africans and either Europeans or East Asians were in the top 10% (F ST > 0.091) and top 15% (F ST > 0.010) of the corresponding EGP distributions of F ST , respectively. Results were similar when the analysis was limited to genes encoding extracellular domains. Accordingly, estimates of F ST suggest that P. falciparum alone did not drive differentiation of GYPA in both populations from sub-Saharan Africa and South Asia, that selective pressure or duration of selection differed between populations in these two malaria endemic regions of the world, or some combination thereof. (Table 1) . None of the estimates of Tajima's D were significantly different from the neutral expectation based on a simulated distribution generated using the coalescent (Schaffner et al. 2005) or when compared to the empirical distribution of D values estimated from EGP exome data. Accordingly, we found no evidence that variation in GYPA differed from expectations under neutrality in the samples studied herein.
Sequence variation in exon 2 of GYPA
GYPA is located in a region with a high estimated recombination rate (Blumenfeld and Huang 1995) . This potentially could reduce the sensitivity of tests that rely on the allele frequency spectra, such as Tajima's D, to detect departures from neutrality across GYPA (Thornton 2005) . Furthermore, if GYPA has been evolving in response to malarial evasion, the effect might be strongest on exon 2, which includes the M and N alleles, and encodes the human extracellular domain that interacts directly with P. falciparum's EBA-175 (Camus and Hadley 1985; Chitnis and Miller 1994; Sim et al. 1994; Tolia et al. 2005) .
We tested whether the pattern of variation in exon 2 differed from other exons of GYPA in two ways. First, we calculated Tajima's D for exon 2 alone. Tajima's D for exon 2 was significantly positive (p < 0.05) in samples from subSaharan Africans, South Asians, and Europeans, but not East Asians (Table 1) . Similar results were obtained when D values in sub-Saharan Africans (p < 0.001), Europeans (p < 0.05), and East Asians (N.S.) were compared to the empirical distribution generated using the EGP data. We also sequenced exon 2 in 949 Human Genome Diversity PanelCentre d'Etude du Polymorphisme Humain (HGDP-CEPH) samples from 52 populations belonging to seven continental groups (Cann et al. 2002) (Table S3) .
Next, we used a sliding windows approach to test if departures from neutral expectations varied along the length of GYPA and to identify the putative selected region(s). Two of the polymorphisms included in this analysis were indel Exon 2 includes only variants present in the exon whereas exon 2 region includes intronic variants present upstream and downstream of exon 2. Statistical significance was assessed using 10,000 permutation tests in DnaSP (Librado and Rozas 2009) n number of individuals, S segregating sites, π average number of nucleotide differences per site, θω Watterson estimator **p < 0.001; *p < 0.01; *p < 0.05 a Tajima (1989) Fig. 3 and Table S4 ). Estimates of Tajima's D were significantly positive for multiple windows across GYPA in samples from Europeans (Fig. 3) . Collectively, these results are consistent with the hypothesis that malaria has driven the evolution of GYPA among sub-Saharan Africans and South Asians. It also suggests that a selective force other than malaria has shaped the evolution of GYPA in Europeans.
Haplotype variation in GYPA
A network of haplotypes separated by mutational steps in a region that has been influenced by balanced selection can have a "dumbbell-like" pattern wherein two clusters of closely related haplotypes are separated from one another by multiple mutation steps. We constructed a reduced median network illustrating the relationships among a total of 34 identified GYPA haplotypes (Fig. 4 and Table S5 ). Five GYPA haplotypes were common (frequency ≥ 5%) and 29 haplotypes were rare (frequency < 5%). Sixteen haplotypes occurred only once in the sample, and seven of these were geographically restricted to sub-Saharan Africa. The two most common haplotypes, H1 and H2, were found in all four populations and account for 48% of sampled chromosomes. H1 contained two SNVs that distinguish the haplotype containing the N allele, whereas H2 contained the two SNVs that define the haplotype containing the M allele. Consistent with these observations, a network of GYPA haplotypes revealed two clusters of common haplotypes connected by a single mutational step to multiple rare haplotypes and separated from one another by multiple mutational steps. Colorcoding the haplotypes according to whether they carried the M or N alleles highlighted this pattern. These results are consistent with balancing selection maintaining the M and N alleles of GYPA in multiple populations and not limited to sub-Saharan Africans and South Asians, and reinforce the suggestion that selective forces other than falciparum malaria have acted upon GYPA.
Discussion
GYPA is a cell-surface glycoprotein that serves as the binding ligand for P. falciparum erythrocyte invasion. It stands out among loci in the human genome as one of the fastest evolving genes. Our results suggest that GYPA evolved under balancing selection among two populations from P. falciparum endemic zones, sub-Saharan Africans, and South Asians, and one population from a P. falciparum non-endemic zone, Europeans. The evidence for balancing selection both within and outside of malarial endemic zones could be explained in two ways: (1) spatially varying selection pressures in response to localized environmental variables have shaped GYPA evolution on a global scale or (2) a single shared selective pressure common to Europeans, subSaharan Africans, and South Asians. Both these interpretations point to a potential, as of yet unidentified, role of GPA in infectious disease pathways beyond that of P. falciparum. Evidence for spatially varying selection pressure is supported by three observations. First, two alleles, M and N, have been maintained at high frequency in all three populations. Second, among sub-Saharan Africans and South Asians, we observe positive and significant values of Tajima's D that are localized to exon 2, which encodes the extracellular domain that interacts directly with P. falciparum. Third, among Europeans, we observe significantly positive values of Tajima's D across multiple protein domains and two alleles separated by multiple mutational steps.
The skew in the allele frequency spectra towards an excess of intermediate frequency variants was observed in sub-Saharan Africans and South Asians and was restricted to exon 2. GYPA exon 2 encodes the extracellular protein domain that interacts directly with P. falciparum's EBA-175 ligand leading to merozoite invasion of human erythrocytes. Haplotype networks for exon 2 in South Asians and sub-Saharan Africans showed two major haplotypes corresponding to the M and N of the MNS blood groups encoded by two non-synonymous variants in exon 2. The maintenance of these two alleles at intermediate frequencies and occurring on separate haplotypes separated by multiple mutational steps supports the hypothesis that this locus has been evolving under balancing selection to P. falciparum. Population subdivision also can lead to significant departures from neutrality and positive values of Tajima's D. However, we do not think that the pattern of variation in exon 2 results from underlying demographic factors for several reasons. First, demographic events are evolutionary forces that affect different genomic regions in a similar manner, whereas natural selection is a locus-specific force causing deviations from the expected neutral variation in both functional variants and markers closely linked to them. We observe a departure from neutrality that is restricted to exon 2. Second, we accounted for underlying demography and mitigated its effect using simulated and empirical distributions to test for statistical significance in each continental population. Third, we detected significant deviations across multiple sub-Saharan populations with different demographic histories. Together, these observations suggest that natural selection, not demography, is responsible for the observed pattern of variation among sub-Saharan Africans and South Asians.
We acknowledge that the statistical tests used are not independent of one another. Unfortunately, there is no straightforward way to correct for this lack of independence given the various statistical tests employed and the numerous population combinations. This is a limitation of our study design.
Balancing selection acts to maintain diversity at a locus most commonly via heterozygote advantage or frequencydependent selection. Many of the mutations that confer resistance to malaria exhibit heterozygote advantage and are deleterious outside of malarial endemic zones (i.e., HbS allele and G6PD A allele) (Tishkoff et al. 2001) . Under a scenario of heterozygote advantage for GYPA, one prediction is that persons who are MN heterozygotes might be more resistant to P. falciparum infection and/or disease progression than individuals homozygous for either allele. However, it remains uncertain if MN heterozygosity provides resistance to malaria.
Under frequency-dependent selection, the advantageous allele would switch back and forth between the M and N alleles and be dependent on the frequency of a corresponding allele encoding P. falciparum's EBA-175-binding antigen. The pattern of variation in the EBA-175-binding domain suggests that selection has maintained amino-acid polymorphism in this region (Ozwara et al. 2001) . However, the specific alleles facilitating the parasite-erythrocyte interaction remain unknown. Therefore, it remains to be determined if the observed patterns in humans and malaria are the result of frequency-dependent selection. Continued research into the relationship between diversity patterns of GYPA's extracellular domain and P. falciparum's EBA-175 antigen will be necessary to determine the type of balancing selection to malarial pressure operating on this locus.
Analysis of exon 2 suggests that balancing selection acted on populations outside of hyperendemic or mesoendemic malarial zones. Specifically, Tajima's D for exon 2 was significant and positive for Europeans and for six of eight European HGDP-CEPH populations tested separately. Moreover, our sliding-window analysis revealed evidence that balancing selection acted on genomic regions beyond the boundaries of exon 2. This observation indicates that the target of balancing selection resides outside of the region encoding the extracellular domain that interacts with P. falciparum, suggesting that a selective force other than, or in combination with, P. falciparum is responsible. In other words, these observations suggest that GYPA has been subject to spatially varying selection, wherein distinct selective pressures have operated in particular environments.
It is challenging to speculate what pathogen, if any, could be driving the pattern of selection observed for Europeans. There are no known pathogens present in Europe that infect erythrocytes and bind to GPA. However, erythrocyte glycoproteins including GPA do bind many viral and microbial pathogens that do no infect the red cell. This observation has been used to develop the hypothesis that glycoproteins serve as decoy receptors. They attract pathogens to enucleated erythrocytes and divert pathogens away from target tissues (Baum et al. 2002; Gagneux and Varki 1999) . It is possible that in the absence of falciparum malaria, allelic variation has been maintained to attract diverse pathogens. Alternatively, a single shared selective pressure common to Europeans, sub-Saharan Africans, and South Asians could result in the pattern of balancing selection observed. However, there are no known pathogens common to all three regions that bind to GPA and infect the erythrocyte. P. falciparum is the only known pathogen that both binds to GPA and infects erythrocytes. Other pathogens bind to GYPA, but do not infect red cells. These include viruses such as rotavirus (Salas et al. 2016) , hepatitis A (Sanchez et al. 2004) , and influenza (Burness and Pardoe 1981) as well as bacteria including Mycoplasma pneumoniae (Baseman et al. 1982) and Escherichia coli (Brooks et al. 1989 ).
Conclusion
Malaria has been a powerful selective force in human evolution. It has shaped the patterns of human genetic variation at multiple loci in the human genome including betaglobin and G6PD (Hamblin and Di Rienzo 2000; Saunders et al. 2002; Tishkoff et al. 2001) . The most virulent form of malaria, P. falciparum, invades the human host by docking to GPA expressed on the erythrocyte surface, specifically the extracellular domain encoded by exon 2 of the GYPA gene. We identified an excess of intermediate frequency variants in exon 2 of GYPA in three continental groups: sub-Saharan Africans, South Asians, and Europeans. Two of these groups (sub-Saharan Africans and South Asians) inhabit regions of the globe with endemic P. falciparum, but Europeans do not. Our results suggest that balancing selection has acted on exon 2 of GYPA in P. falciparum endemic regions, but that a selective force other than P. falciparum has acted on GYPA in European populations. This conclusion is not entirely surprising and indeed, for genes encoding proteins that interact with a multitude of environmental factors, the pattern of selection might be expected to be complex and characterized by the impact of different selective forces, with varied strength, and acting at different periods of human evolutionary history.
Materials and methods

Populations
GYPA was sequenced in 85 individuals (i.e., the discovery panel) including 26 sub-Saharan Africans, 17 Europeans, 14 East Asians, and 28 South Asians ( Fig. 1 and Table S1 ). The sub-Saharan Africans consisted of samples from ten ethnic groups (2 Biaka, 3 Alur, 3 Hema, 3 Nande, 3 Mbuti Pygmy, 1 Kenyan, 3 Nigerians, 2 San, 3 Sotho, and 3 Nguni). The South Asian samples were from ten populations (3 Brahmin, 3 Chenchu, 3 Irula, 3 Khondadora, 3 Kshatriya, 3 Madiga, 3 Mala, 3 Relli, 1 Santal, and 3 Yadava). East Asians were represented by samples from five populations (3 Han Chinese, 3 Cambodians, 2 Vietnamese, 3 Japanese, and 3 Aboriginal Malay) and Europeans by samples from seven populations (3 French, 3 Northern Europeans, 3 Poles, 4 Daghestani, 1 Italian, 1 Finn, and 2 Turku). To increase the breadth of populations studied and samples tested, we sequenced exon 2 of GYPA in 954 individuals from 52 populations from sub-Saharan Africa, the Middle East, Europe, East Asia, South/Central Asia, the Americas, and Oceania (Table S6) that are part of the Human Genome Diversity Panel-Centre d'Etude du Polymorphisme Humain (HGDP-CEPH) (Cann et al. 2002) . Duplicate samples and first-degree relatives were removed (Rosenberg 2006) .
DNA sequencing
A set of seven primer pairs was used to amplify a total of 4 kb of sequence including each exon and approximately 1 kb of sequence upstream and downstream of each exon. The HGDP-CEPH samples were sequenced only for the region containing exon 2. Sequence data were generated using internal primers on either an ABI 3700 or ABI 3730xl automated sequencer. PCR and sequencing primers are provided in Table S7 . Sequence trace files were aligned and genotype calls were made using Codon Code (Dedham, MA). Polymorphic sites were confirmed by visual inspection of the traces. Genotype data are available in the Supplementary data online.
Statistical analysis
Pairwise and population-specific F ST were calculated using Arlequin version 3.1 (Excoffier et al. 2005 ). Tajima's D detects departures from neutrality based on the allele frequency spectra and was calculated using DnaSP Version 5.0 (http ://www.ub.edu/dnas p/) (Librado and Rozas 2009; Tajima 1989) . Statistical significance of each test was assessed using the coalescent as implemented in the program COSI (Schaffner et al. 2005 ). This program incorporates population growth into the modeling procedure, the inclusion of which more accurately reflects the demographic history of humans. We used 10,000 replicates and modeled the assumed demographic history of each of our four populations. For Africans, East Asians, and Europeans, the default parameters were implemented. For South Asians, we selected parameters that reflected what is known about South Asian demographic history. The parameter file used in our COSI analysis is provided in Supplemental Data File S1. All exons of GYPA and exons encoding just the extracellular domain were analyzed in each population. Genotypes were phased using fastPhase (Scheet and Stephens 2006) . Haplotype networks were constructed using Network v4.5.1.0 (Fluxus-Engineering.com) (Bandelt et al. 1995; Polzin and Daneshmand 2003) .
